Maccura and Qiagen Form Next-Gen Sequencing JV in China
publication date: May 5, 2017
China's Maccura Biotechnology formed a joint venture with Qiagen of the Netherlands to develop and market Qiagen's GeneReader NGS system in China. Maccura is a China IVD company. It will own 60% of the JV, which is named Maqgen, while Qiagen will own the rest. Qiagen claims the GeneReader NGS System is the world's first complete Sample-to-Insight reader and makes NGS available to any laboratory. The JV will focus initially on research use of the machine and broaden that to include Class III hospital networks. More details....
Stock Symbols: (SHZ: 300463) (NSDQ: QGEN)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.